Joe - ChimeraResearchGroup· @ChimeraResearch · X·· 2026-04-21评分60
正文 · 原文
$MDNAF $MDNA.to outstanding data MDNA113 in NHP presented at #AACR26
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026
热度 14 · 12 赞 · 0 回复 · 2 转发
会议摘要
4342按 代号 MDNA113 对上
MDNA113 is a masked conditionally activated tumor-targeted anti-PD1-IL-2SK with superior safety and therapeutic propertiesMinh D. To, Rosemina Merchant, Aanchal Sharma, Fahar Merchant
读摘要原文 →来源:Joe - ChimeraResearchGroup · x.com
